Search for: "David Boundy"
Results 81 - 89
of 89
Sorted by Relevance
|
Sort by Date
4 Oct 2021, 1:52 pm
Chien, Piloting Applicant-Initiated 101 Deferral Through A Randomized Controlled Trial, 2019 Patently-O Patent Law Journal 1. (2019.Chien.DeferringPSM) David A. [read post]
27 Jan 2021, 11:36 am
Chien, Piloting Applicant-Initiated 101 Deferral Through A Randomized Controlled Trial, 2019 Patently-O Patent Law Journal 1. (2019.Chien.DeferringPSM) David A. [read post]
29 Mar 2021, 6:30 pm
Chien, Piloting Applicant-Initiated 101 Deferral Through A Randomized Controlled Trial, 2019 Patently-O Patent Law Journal 1. (2019.Chien.DeferringPSM) David A. [read post]
10 Jul 2007, 10:02 am
” Those interested in trying further steps to limit these rule changes should send an email to David Boundy of Cantor Fitzgerald at: DBoundy@Cantor.com He is exploring two additional avenues: (a) Congressional oversight. [read post]
29 Jan 2019, 11:48 am
Articles: David A. [read post]
8 Oct 2008, 7:10 pm
Belzer via David Boundy: WHAT YOU NEED TO DO Obtain the documentation from the PTO. [read post]
30 Apr 2008, 8:57 pm
” Among the many still smoldering hate mails, David Boundy of Cantor Fitzgerald fired off angry comments about proposed Markush Rules and the PTO’s Initial Regulatory Flexibility Analysis (IRFA) and Paperwork Reduction Act Information Collection Request. [read post]
9 Feb 2015, 8:49 am
Remedies: adjust stakes: attorneys’ fees/boundies to get right cases before the courts. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
